Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-25-059529
Filing Date
2025-06-13
Accepted
2025-06-13 20:06:37
Documents
1
Period of Report
2025-05-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2518028-4_4aseq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2518028-4_4aseq1.xml 4/A 4609
  Complete submission text file 0001104659-25-059529.txt   6212
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Issuer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address AZRIELI CENTER ROUND TOWER, 30TH FLOOR TEL AVIV L3 6701101
Business Address
Myers Michael (Reporting) CIK: 0001959547 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37846 | Film No.: 251048195